Can You Get Hepatitis C From Sharing a Straw?

Probably, but nobody has proven it. Transmission from a shared snorting straw is biologically plausible and supported by real epidemiological signals, and no study has ever isolated straw-sharing as the route of infection in an actual person. Rehab sites state it as settled fact, forums call it a myth, and both are overstating what is known. None of which changes what to do, because using your own tube is close to free and the downside is a chronic liver infection.

Three things have to line up, and all three are documented

Hepatitis C is blood-borne. For a straw to transmit it you need blood on the equipment, virus surviving in that blood, and a route into the next person’s bloodstream.

The nose bleeds. Stimulants constrict the vessels feeding the nasal lining, starving that tissue of oxygen, and the powder itself is abrasive. Regular users develop a fragile, easily bleeding mucosa long before anything dramatic like a septal perforation shows up, a progression our cocaine harm reduction guide covers. Visible nosebleeds are not the threshold. Micro-abrasions that never produce a drip are enough to put blood on a tube and to let virus in at the other end.

Virus is in nasal fluid, not only in blood. McMahon and colleagues first detected HCV RNA in an intranasal drug user’s nasal secretions in 2004, in the one participant of five with the highest viral load. A larger 2008 study at a New York clinic confirmed blood and HCV RNA in both the nasal secretions and the snorting implements of infected users.

The virus is durable. It survives drying: at least 16 hours in dried plasma at room temperature, and up to 5 days on a serum-coated surface. A tube passed around a table over one night sits comfortably inside that window.

Every link has evidence behind it. What is missing is a study that watched all three happen in one person.

What the evidence does and does not establish

Two studies do most of the work, and they fail in opposite directions.

Fernandez and colleagues, writing in Obstetrics and Gynecology in 2016, surveyed 189 HCV-infected pregnant women about transmission risks. 178 of them, 94 percent, reported snorting drugs, and 164 of those, 92 percent, reported sharing straws. Only 136, 72 percent, reported intravenous drug use, making shared snorting equipment significantly more common than shared injection equipment (P<.001). The same team tested straws confiscated by law enforcement from unrelated people and found human blood on 24 percent of the 54 tested.

The limitation, stated plainly: 72 percent of that cohort also injected. Injection is a far more efficient route for HCV, so for most of these women the straw is not the likeliest explanation and the study cannot separate the two. A subgroup of 29, 15 percent, reported straw-sharing and denied every risk factor except sexual contact, which is as close as the paper gets to isolating it.

Simmons and colleagues fixed that flaw in 2022 in the Journal of Studies on Alcohol and Drugs. They analysed 10,106 people from the 2011 to 2018 NHANES survey, restricted to people who had never injected an illicit substance. Cocaine use carried 4.48 times the adjusted odds of ever having HCV (95% CI 2.36 to 8.50), controlling for age, race, sex, education, income and immigrant status.

Removing injection as a confounder is the strongest design available here, and a fourfold association in never-injectors is hard to wave away. But it measures cocaine use, not straw-sharing, and people who use cocaine differ from those who do not in ways those covariates miss: sexual networks, tattooing, incarceration. Residual confounding is real.

McMahon and Tortu’s 2003 review reached the same verdict and little has changed since. Some epidemiological support, most studies methodologically limited, biology that does not refute intranasal transmission.

So: plausible mechanism, confirmed contamination of real equipment, a solid signal in never-injectors, no proof of the route itself. Not a myth, not a settled fact.

Why the uncertainty does not change the advice

Uncertainty matters when acting on it is expensive. Here it is not. Not sharing costs a tube and slightly more coordination; the downside if the risk is real is a chronic liver infection. When one side of a decision is nearly free and the other is a blood-borne virus, you act on the plausible risk rather than wait for proof. Same reasoning as not sharing a razor.

Rolled banknotes are a specifically bad choice

Bills are the default improvised tube and the worst available option. They circulate, having been handled by strangers, sat in tills and pockets, and been rolled by other people. Their fibres hold residue, because currency is woven cotton and linen rather than a smooth surface, so it absorbs biological material and cannot be cleaned. A tightly rolled bill has a stiff cut edge that scrapes the nasal lining, and that abrasion is what causes the bleeding that creates the risk in the first place. And nobody treats a bill as personal equipment, so it gets passed around without anyone deciding to share.

Safer snorting equipment: the practical version

None of this makes snorting safe. It removes one avoidable harm.

• One tube per person, never passed. Carry a personal reusable tube. DanceSafe sells these explicitly as a hepatitis C prevention measure.
• Label or colour-code them in a group. The failure mode is not deciding to share, it is tubes getting mixed up on a table. Marker or tape solves it.
• No sharp or cut edges. Skip cut straws, rolled cards and jagged pen barrels. Smooth, rounded ends only.
• Wash reusable tubes in warm soapy water and dry them fully. Being cleanable is the whole advantage over paper.
• Do not share the surface or the card either. Blood transfers to the plate and the chopping card, not just the tube.
• Saline rinse and recovery time. Less mucosal damage means less bleeding means less to transmit, covered in the nasal care section of our cocaine harm reduction guide.

Same logic covers a shared pipe, where burnt and cracked lips are why personal mouthpieces are the standard answer.

If you have shared equipment, get tested

This part should defuse the anxiety rather than feed it, because hepatitis C is curable. A meta-analysis of 12 studies covering 711 people who use drugs found a pooled sustained virological response of 89.8 percent (95% CI 85.9 to 92.7) on one direct-acting antiviral regimen, and newer pan-genotypic regimens do better. Treatment is usually 8 to 12 weeks of oral tablets.

Testing starts with an antibody test, available at most clinics, many syringe service programs, and by mail. A positive is followed by an RNA test, since some people clear the virus on their own. Antibodies take weeks to appear, so a test taken immediately after an incident can miss it. For anyone who has shared equipment over the years, the realistic move is one test rather than years of worrying about it.

Sharing straws is a real concern rather than a proven route, and the distinction changes nothing about what to do tonight. For the wider picture on stimulant risks, see our cocaine harm reduction guide and our breakdown of levamisole in cocaine.

Sources

PMID 17464909 | PMID 22013220 | PMID 27400008 | PMID 18764772 | PMID 15132748 | PMID 35254242 | PMID 14986874 | PMID 34315488